Akoya Biosciences (AKYA) Competitors $2.28 +0.09 (+4.11%) (As of 12:43 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AKYA vs. AEHR, NAUT, SENS, QSI, SEER, FEIM, KEQU, MASS, OWLT, and CLIRShould you be buying Akoya Biosciences stock or one of its competitors? The main competitors of Akoya Biosciences include Aehr Test Systems (AEHR), Nautilus Biotechnology (NAUT), Senseonics (SENS), Quantum-Si (QSI), Seer (SEER), Frequency Electronics (FEIM), Kewaunee Scientific (KEQU), 908 Devices (MASS), Owlet (OWLT), and ClearSign Technologies (CLIR). These companies are all part of the "measuring and control equipment" industry. Akoya Biosciences vs. Aehr Test Systems Nautilus Biotechnology Senseonics Quantum-Si Seer Frequency Electronics Kewaunee Scientific 908 Devices Owlet ClearSign Technologies Akoya Biosciences (NASDAQ:AKYA) and Aehr Test Systems (NASDAQ:AEHR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, community ranking, earnings and risk. Which has more volatility & risk, AKYA or AEHR? Akoya Biosciences has a beta of 1.34, meaning that its stock price is 34% more volatile than the S&P 500. Comparatively, Aehr Test Systems has a beta of 2.03, meaning that its stock price is 103% more volatile than the S&P 500. Does the media prefer AKYA or AEHR? In the previous week, Aehr Test Systems had 1 more articles in the media than Akoya Biosciences. MarketBeat recorded 3 mentions for Aehr Test Systems and 2 mentions for Akoya Biosciences. Akoya Biosciences' average media sentiment score of 1.88 beat Aehr Test Systems' score of 1.21 indicating that Akoya Biosciences is being referred to more favorably in the media. Company Overall Sentiment Akoya Biosciences Very Positive Aehr Test Systems Positive Does the MarketBeat Community prefer AKYA or AEHR? Aehr Test Systems received 98 more outperform votes than Akoya Biosciences when rated by MarketBeat users. However, 60.71% of users gave Akoya Biosciences an outperform vote while only 58.41% of users gave Aehr Test Systems an outperform vote. CompanyUnderperformOutperformAkoya BiosciencesOutperform Votes3460.71% Underperform Votes2239.29% Aehr Test SystemsOutperform Votes13258.41% Underperform Votes9441.59% Do institutionals and insiders hold more shares of AKYA or AEHR? 79.4% of Akoya Biosciences shares are held by institutional investors. Comparatively, 69.7% of Aehr Test Systems shares are held by institutional investors. 7.3% of Akoya Biosciences shares are held by insiders. Comparatively, 6.2% of Aehr Test Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is AKYA or AEHR more profitable? Aehr Test Systems has a net margin of 49.63% compared to Akoya Biosciences' net margin of -66.77%. Aehr Test Systems' return on equity of 29.31% beat Akoya Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Akoya Biosciences-66.77% -162.99% -32.76% Aehr Test Systems 49.63%29.31%25.07% Do analysts rate AKYA or AEHR? Akoya Biosciences presently has a consensus target price of $5.43, suggesting a potential upside of 147.88%. Aehr Test Systems has a consensus target price of $25.00, suggesting a potential upside of 96.85%. Given Akoya Biosciences' higher probable upside, research analysts clearly believe Akoya Biosciences is more favorable than Aehr Test Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Akoya Biosciences 0 Sell rating(s) 5 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.38Aehr Test Systems 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has higher valuation and earnings, AKYA or AEHR? Aehr Test Systems has lower revenue, but higher earnings than Akoya Biosciences. Akoya Biosciences is trading at a lower price-to-earnings ratio than Aehr Test Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAkoya Biosciences$86.82M1.25-$63.32M-$1.18-1.86Aehr Test Systems$66.22M5.68$33.16M$0.9812.96 SummaryAehr Test Systems beats Akoya Biosciences on 11 of the 18 factors compared between the two stocks. Ad Porter & CompanyElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. Get Akoya Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AKYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AKYA vs. The Competition Export to ExcelMetricAkoya BiosciencesAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$108.54M$5.65B$5.36B$8.94BDividend YieldN/A0.42%5.33%4.05%P/E Ratio-1.8625.77117.6718.00Price / Sales1.254.601,424.20155.72Price / CashN/A44.0042.8038.60Price / Book7.822.817.356.66Net Income-$63.32M$515,312.50$118.46M$224.93M7 Day Performance-0.45%2.45%3.40%2.50%1 Month Performance-19.78%-0.75%2.49%10.24%1 Year Performance-53.60%-17.20%36.17%30.14% Akoya Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AKYAAkoya Biosciences2.5973 of 5 stars$2.28+4.1%$5.43+138.1%-53.6%$113.00M$96.63M-1.9390Positive NewsAEHRAehr Test Systems2.4982 of 5 stars$12.51+5.2%$25.00+99.8%-47.3%$370.67M$66.22M12.1390News CoveragePositive NewsNAUTNautilus Biotechnology2.4926 of 5 stars$2.28+1.8%$4.50+97.4%-22.5%$286.29MN/A-4.09130Positive NewsSENSSenseonics1.4751 of 5 stars$0.31+0.9%$2.00+536.5%-51.5%$187.05M$22.21M-2.4290Analyst ForecastQSIQuantum-Si3.0702 of 5 stars$1.18-6.0%$3.25+176.6%-34.5%$167.69M$2.27M-1.88150Gap UpHigh Trading VolumeSEERSeer1.3353 of 5 stars$2.49+0.8%$3.00+20.5%+49.7%$146.83M$14.18M-1.90160FEIMFrequency Electronics2.9788 of 5 stars$13.84-1.2%N/A+30.7%$132.45M$55.27M22.60200Upcoming EarningsShort Interest ↓Positive NewsKEQUKewaunee Scientific0.9395 of 5 stars$42.77+2.5%N/A+141.2%$122.84M$202.31M6.701,006Upcoming EarningsAnalyst UpgradeNews CoverageMASS908 Devices3.5059 of 5 stars$2.81+2.6%$8.00+184.7%-62.7%$97.85M$55.16M-1.5760Positive NewsOWLTOwlet1.2175 of 5 stars$4.88+0.4%N/A-7.5%$78.26M$78.58M-2.01106Positive NewsHigh Trading VolumeCLIRClearSign Technologies3.2176 of 5 stars$1.18flat$6.00+408.5%+0.0%$59.27M$2.40M-10.7310Short Interest ↓Gap Up Related Companies and Tools Related Companies AEHR Competitors NAUT Competitors SENS Competitors QSI Competitors SEER Competitors FEIM Competitors KEQU Competitors MASS Competitors OWLT Competitors CLIR Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AKYA) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akoya Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akoya Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
